or Try an Advanced Search...

    Technical Analysis for SERA - Sera Prognostics, Inc

    Grade Last Price % Change Price Change
    F 6.09 0.91% 0.06
    SERA closed down 2.43 percent on Wednesday, November 20, 2024, on 78 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical SERA trend table...
    Date Alert Name Type % Chg
    Outside Day Range Expansion 0.91%
    Wide Bands Range Expansion 0.91%
    Oversold Stochastic Weakness 0.91%
    Bullish Engulfing Bullish -1.54%
    NR7 Range Contraction -1.54%
    NR7-2 Range Contraction -1.54%
    Narrow Range Bar Range Contraction -1.54%
    Wide Bands Range Expansion -1.54%
    Oversold Stochastic Weakness -1.54%
    NR7 Range Contraction 0.08%
    Older End-of-Day Signals for SERA ...

       Recent Intraday Alerts

    Alert Time
    Fell Below Previous Day's Low about 1 hour ago
    Down 2 % about 1 hour ago
    Down 1% about 4 hours ago
    Up 1% about 4 hours ago
    Rose Above Previous Day's High 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    SERA Chart by TradingView
    Basic chart:

    Profile

    Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preeclampsia, molecular time-to-birth, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.
    Classification
    Sector: Healthcare
    Industry: Diagnostics & Research
    Keywords: Fertility Obstetrics Childbirth Women's Health Human Pregnancy Midwifery Pregnancy Preterm Birth

    Is SERA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
    Sep 4 Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference
    Aug 9 Sera Prognostics, Inc. (SERA) Q2 2024 Earnings Call Transcript
    Aug 8 Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024
    Jul 31 Cencora (COR) Surpasses Q3 Earnings and Revenue Estimates
    Jul 25 Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024
    Jul 9 Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial
    Jul 1 Sera Prognostics joins Russell 2000, Russell 3000 indexes
    Jul 1 SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION
    Jun 20 Sera Prognostics, Inc. (NASDAQ:SERA) most popular amongst individual investors who own 31% of the shares, institutions hold 29%
    See more SERA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.355
    52 Week Low 1.805
    Average Volume 99,448
    200-Day Moving Average 8.09
    50-Day Moving Average 7.28
    20-Day Moving Average 7.15
    10-Day Moving Average 6.69
    Average True Range 0.59
    RSI (14) 39.02
    ADX 18.49
    +DI 15.70
    -DI 25.59
    Chandelier Exit (Long, 3 ATRs) 7.02
    Chandelier Exit (Short, 3 ATRs) 7.67
    Upper Bollinger Bands 8.60
    Lower Bollinger Band 5.69
    Percent B (%b) 0.12
    BandWidth 40.74
    MACD Line -0.32
    MACD Signal Line -0.14
    MACD Histogram -0.1775
    Fundamentals Value
    Market Cap 183.12 Million
    Num Shares 30.4 Million
    EPS -1.23
    Price-to-Earnings (P/E) Ratio -4.90
    Price-to-Sales 806.20
    Price-to-Book 3.37
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.67
    Resistance 3 (R3) 6.70 6.52 6.56
    Resistance 2 (R2) 6.52 6.35 6.50 6.53
    Resistance 1 (R1) 6.27 6.25 6.18 6.24 6.49
    Pivot Point 6.09 6.09 6.05 6.08 6.09
    Support 1 (S1) 5.85 5.93 5.76 5.82 5.57
    Support 2 (S2) 5.67 5.83 5.65 5.53
    Support 3 (S3) 5.42 5.67 5.50
    Support 4 (S4) 5.39